Treatment of Dyssomnias and Parasomnias in Childhood

被引:0
作者
Suresh Kotagal
机构
[1] Mayo Clinic,Neurology, Pediatrics and the Center for Sleep Medicine
来源
Current Treatment Options in Neurology | 2012年 / 14卷
关键词
Narcolepsy; Idiopathic hypersomnia; Kleine Levin syndrome; Restless legs syndrome; Neurodevelopmental disorders; Sleep walking; Confusional arousals; Rapid eye movement sleep disorder; Central sleep apnea; Obstructive sleep apnea; Treatment; Dyssomnias; Parasomnias; Childhood; Pediatric;
D O I
暂无
中图分类号
学科分类号
摘要
Dyssomnias are sleep disorders associated with complaints of insomnia or hypersomnia. The daytime sleepiness of narcolepsy is treated by a combination of planned daytime naps, regular exercise medications such as modafinil, or salts of methylphenidate, or amphetamine. Cataplexy that accompanies narcolepsy is treated with anticholinergic agents, selective serotonin reuptake inhibitors, or sodium oxybate. Children with neurodevelopmental disabilities such as autism have sleep initiation and maintenance difficulties on a multifactorial basis, with favorable response to melatonin in some patients. Childhood onset restless legs syndrome is often familial, associated with systemic iron deficiency, and responsive to iron supplementation and gabapentin. Parasomnias are episodic phenomena events which occur at the sleep -- wake transition or by intrusion on to sleep. Arousal parasomnias such as confusional arousals and sleep walking can sometimes be confused with seizures. A scheme for differentiating arousal parasomnias from nocturnal seizures is provided. Since arousal parasomnias are often triggered by sleep apnea, restless legs syndrome, or acid reflux, treatment measures directed specifically at these disorders often helps in resolution. Clonazepam provided in a low dose at bedtime can also alleviate sleep walking and confusional arousals. Obstructive sleep apnea affects about 2 percent of children. Adeno-tonsillar hypertrophy, cranio-facial anomalies, and obesity are common predisposing factors. Mild obstructive sleep apnea can be treated using a combination of nasal corticosteroids and a leukotriene antagonist. Moderate to severe obstructive sleep apnea are treated with adeno-tonsillectomy, positive airway pressure breathing devices, or weight reduction as indicated. This paper provides an overview of the topic, with an emphasis on management steps. Where possible, the level of evidence for treatment recommendations is indicated.
引用
收藏
页码:630 / 649
页数:19
相关论文
共 211 条
[1]  
Nevsimalova S(2009)Narcolepsy in childhood Sleep Med Rev 13 169-80
[2]  
Lin L(1999)The sleep disorder, canine narcolepsy, is caused by a mutation in the hypocretin (orexin) receptor 2 gene Cell 98 356-76
[3]  
Faraco J(2000)Hypocretin (orexin) deficiency in human narcolepsy Lancet 35 39-40
[4]  
Li R(2006)Staying awake for dinner: hypothalamic integration of sleep, feeding and circadian rhythms Prog Brain Res 153 243-52
[5]  
Nishino S(2002)Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating and movement Am J Physiol Regul Integr Comp Physiol 283 R1079-86
[6]  
Ripley B(2011)Cerebrospinal fluid hypocretin 1 deficiency, overweight and metabolic dysregulation in patients with narcolepsy J Clin Sleep Med 7 653-8
[7]  
Overeem S(2009)Implementation of a school based state policy to increase physical activity J Sch Health 79 231-8
[8]  
Saper CB(2007)Treatment of narcolepsy and other hypersomnias of central origin Sleep 30 1712-27
[9]  
Wu MF(2007)Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin Sleep 30 1705-6
[10]  
John J(2011)Narcolepsy, idiopathic hypersomnolence, and related conditions Clin Med 11 282-67